|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1301 Pennsylvania Ave NW |
Address2 | Suite 800 |
| City | WASHINGTON |
State | DC |
Zip Code | 20004-1725 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60601 |
Country | USA |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
||||||||
| TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Paul G Billings |
Date | 10/20/2015 5:44:03 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution including the following legislation: H.Con.Res.27 - Establishing the budget for the United States Government for fiscal year 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025 S.Con.Res.11 An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025; H.R. 3049 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; S. 1800 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; H.R. 2578 Commerce, Justice, Science, and Related Agencies Appropriations; Issues related to Commerce, Justice, Science, and Related Agencies Appropriations; H.R. 2685 Defense Appropriations; S. 1558 Defense Appropriations; H.R. 2822 Interior, Environment, and Related Agencies Appropriations; S. 1645 Interior, Environment, and Related Agencies Appropriations; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; H.R. 2772 State, Foreign Operations, and Related Programs Appropriations; S. 1725 State, Foreign Operations, and Related Programs Appropriations; H.R. 2577 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations. Issues related to the President's Budget; Issues related to the Budget Control Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution including the following legislation: H.R.185, Regulatory Accountability Act of 2015; H.R.427, Regulations from the Executive in Need of Scrutiny Act of 2015; H.R.758, Lawsuit Abuse Reduction Act of 2015; H.R.1029, EPA Science Advisory Board Reform Act of 2015; H.R.1030, Secret Science Reform Act of 2015; H.R.1044, To amend the Clean Air Act to modify the application of certain provisions regarding the inclusion of entire metropolitan statistical areas within nonattainment areas, and for other purposes.; H.R.1320, Commonsense Legislative Exceptional Events Reforms Act of 2015; H.R.1327, ORDEAL Act of 2015; H.R.1388, Clean Air, Strong Economies Act; H.R.1558, Resolving Environmental and Grid Reliability Conflicts Act of 2015; H.R.1759, ALERT Act of 2015; H.R.1993, Flexibility to Farm Act; H.R.2042, Ratepayer Protection Act of 2015; H.R.2111, Wasteful EPA Programs Elimination Act of 2015; H.R.2367, Opportunity for Military Academies and Readiness Act; H.R.2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; S.226, Regulations From the Executive in Need of Scrutiny Act of 2015; S.543, EPA Science Advisory Board Reform Act of 2015; S.544, Secret Science Reform Act of 2015; S.638, Commonsense Legislative Exceptional Events Reforms Act of 2015; S.639, Agency PAYGO for Greenhouse Gases Act; S.640, ORDEAL Act of 2015; S.727, BTU Act of 2015; S.751, CASE Act; S.846, Small Business Regulatory Sunset Act of 2015; S.848, Resolving Environmental and Grid Reliability Conflicts Act of 2015; S.1324, Affordable Reliable Electricity Now Act of 2015; S.1393, REPAIR Act; S.1645, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; S.2072, A bill to require the Administrator of the Environmental Protection Agency to establish a program under which the Administrator shall defer the designation of an area as a nonattainment area for purposes of the 8-hour ozone national ambient air quality standard if the area achieves and maintains certain standards under a voluntary early action compact plan.Issues related to air pollution and health; Issues related to air pollution from vehicles and fuels; Issues related to air pollution from power plants and other stationary sources; Issues related to home heating oil; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations. Issues related to the President's Budget; Issues related to the Budget Control Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Council on Environmental Quality (CEQ), White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.2 Medicare Access and CHIP Reauthorization Act of 2015; H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; H.R. 2685 Defense Appropriations; S. 1558 Defense Appropriations; H.R. 2822 Interior, Environment, and Related Agencies Appropriations; S. 1645 Interior, Environment, and Related Agencies Appropriations; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; H.R. 2772 State, Foreign Operations, and Related Programs Appropriations; S. 1725 State, Foreign Operations, and Related Programs Appropriations; H.R. 2577 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Housing & Urban Development - Dept of (HUD), Treasury - Dept of, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures Act; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; H.R. 3020 Labor, Health and Human Services, Education, and Related Agencies Appropriations; S. 1695 Labor, Health and Human Services, Education, and Related Agencies Appropriations; H.R.3520 Pulmonary Hypertension Research and Diagnosis Act of 2015; S.1177 Every Child Achieves Act of 2015;Issues related to research at the National Institutes of Health; Issues related to the President's Budget; Issues related to the Budget Control Act; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease. H.R.2 Medicare Access and CHIP Reauthorization Act of 2015; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1549 Care Planning Act of 2015; Issues related to the Affordable Care Act; Issues related to lung cancer screening; Issues related to asthma; Issues related to durable medical equipment; Issues related to the President's Budget; Issues related to the Budget Control Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to nonprofit postal rates.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease.S. 1313 Strong Lungs, Strong Lives Act; S. 1376 National Defense Authorization Act for Fiscal Year 2016; HR 1735 - National Defense Authorization Act for Fiscal Year 2016; H.R. 2685 Defense Appropriations; S. 1558 Defense Appropriations; H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations;H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations. Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to tobacco cessation coverage.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD), Navy - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.185, Regulatory Accountability Act of 2015; H.R.427, Regulations From the Executive in Need of Scrutiny Act of 2015; H.R.478, Protecting Children from Electronic Cigarette Advertising Act of 2015; H.R.662, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2015; H.R.1517, SMOKE Act; Smuggled Tobacco Prevention Act; S.430, Protecting Children from Electronic Cigarette Advertising Act of 2015;S.441, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2015;S.450, Tobacco Tax Equity Act of 2015;HR 2058 Deeming Clarification Act of 2015; HR 1749 STOP Act; S. 1129 Tobacco Tax and Enforcement Act; S. 1376 National Defense Authorization Act for Fiscal Year 2016; H.R. 3049 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; Issues related to Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; H.R. 2685 Defense Appropriations; S. 1558 Defense Appropriations; H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; H.R. 2577 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to Transportation, Housing and Urban Development, and Related Agencies Appropriations; H.R. 3656 Tobacco to 21 Act; S.2100 Tobacco to 21 Act; H.R.3042 Stop Tobacco Sales to Youth Act of 2015; H.R.3242 Child Nicotine Poisoning Prevention Act of 2015; Issues related to tobacco trade; Issues related to the Tobacco Control Act; Issues related to the Affordable Care Act; Issues related to tobacco smuggling; Issues related to smokefree air; Issues related to tobacco cessation coverage; Issues related to the President's budget;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), White House Office, U.S. Trade Representative (USTR), Health & Human Services - Dept of (HHS), Housing & Urban Development - Dept of (HUD), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease. S. 1129 Tobacco Tax and Enforcement Act; S 450 Tobacco Tax Equity Act; Issues related to tobacco taxes. Issues related to nonprofit organizations. Issues related to charitable giving.Issues related to the President's Budget; Issues related to the Budget Control Act;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to the prevention and treatment of lung disease. H.R. 2029 Military Construction, Veterans Affairs, and Related Agencies Appropriations; Issues related to Military Construction, Veterans Affairs, and Related Agencies Appropriations; H.R.2237 Helping Veterans Exposed to Burn Pits Act; H.R. 719 Continuing Appropriations Act, 2016; H.J.Res.61 FY2016 Continuing Appropriations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |